Current methods of antibody detection, such as conventional serological assays, are limited in terms of the amount of ...

Researchers at Texas Biomedical Research Institute and the University of Chicago have uncovered a mechanism that SARS-CoV-2, ...

Marketed as BNT327, the PD-L1xVEGF-A bispecific antibody has the potential to become what the involved parties believe is a ...

JNJ-79635322 shows favorable responses and manageable safety in BCMA/GPRC5D-naïve patients with relapsed/refractory multiple ...

Not all medicines and/or indications presented in this report may be approved for use in all countries. Please note data included in this report are based on EU data and may vary depending on local ...

A proteomics-driven 24-protein classifier improves the differentiation of thyroid adenoma and carcinoma, retrospectively and ...

The antimitotic properties of parthenolide, a natural compound with known anticancer activity, have been largely ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Data to be presented at ASCO reflect Boehringer's broad pipeline and growing body of evidence supporting innovative therapies for various ...

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

Zilovertamab vedotin is Merck’s investigational antibody-drug conjugate ... often migrating to other parts of the body. DLBCL accounts for approximately 25-30% of all NHLs worldwide.